Freeman Mason

Chief Medical OfficerCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Feb 27, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$91
Net Open-Market Flow
-$91
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2023Tender(U)2K40K
Feb 24, 2023Tender(U)1000
Feb 24, 2023Disposed to issuer(D)40K0
Jun 10, 2022Sell(S)6$15.21$912K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2023Disposed to issuer(D)145K0
Feb 24, 2023Disposed to issuer(D)30K0
Feb 24, 2023Disposed to issuer(D)120K0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-013268) within minutes of acceptance. Every field above traces to the original document. Verify it directly: